Correlation Between Cytodyn and Cardiff Oncology
Can any of the company-specific risk be diversified away by investing in both Cytodyn and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytodyn and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytodyn and Cardiff Oncology, you can compare the effects of market volatilities on Cytodyn and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytodyn with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytodyn and Cardiff Oncology.
Diversification Opportunities for Cytodyn and Cardiff Oncology
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cytodyn and Cardiff is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Cytodyn and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and Cytodyn is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytodyn are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of Cytodyn i.e., Cytodyn and Cardiff Oncology go up and down completely randomly.
Pair Corralation between Cytodyn and Cardiff Oncology
Given the investment horizon of 90 days Cytodyn is expected to under-perform the Cardiff Oncology. But the otc stock apears to be less risky and, when comparing its historical volatility, Cytodyn is 1.29 times less risky than Cardiff Oncology. The otc stock trades about -0.09 of its potential returns per unit of risk. The Cardiff Oncology is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 231.00 in Cardiff Oncology on September 11, 2024 and sell it today you would earn a total of 13.00 from holding Cardiff Oncology or generate 5.63% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Cytodyn vs. Cardiff Oncology
Performance |
Timeline |
Cytodyn |
Cardiff Oncology |
Cytodyn and Cardiff Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cytodyn and Cardiff Oncology
The main advantage of trading using opposite Cytodyn and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytodyn position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.Cytodyn vs. Madrigal Pharmaceuticals | Cytodyn vs. Scpharmaceuticals | Cytodyn vs. Akero Therapeutics | Cytodyn vs. Cardiff Oncology |
Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |